Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy
Van der Kwast, T, Al Daoud, N, Collette, L, Sykes, J, Thoms, J, Milosevic, M, Bristow, R.G, Van Tienhoven, G, Warde, P, Mirimanoff, R.-O, Bolla, M
Published in European journal of cancer (1990) (01.06.2012)
Published in European journal of cancer (1990) (01.06.2012)
Get full text
Journal Article
A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients
Beck, D, Thoms, J A I, Palu, C, Herold, T, Shah, A, Olivier, J, Boelen, L, Huang, Y, Chacon, D, Brown, A, Babic, M, Hahn, C, Perugini, M, Zhou, X, Huntly, B J, Schwarzer, A, Klusmann, J-H, Berdel, W E, Wörmann, B, Büchner, T, Hiddemann, W, Bohlander, S K, To, L B, Scott, H S, Lewis, I D, D'Andrea, R J, Wong, J W H, Pimanda, J E
Published in Leukemia (01.02.2018)
Published in Leukemia (01.02.2018)
Get full text
Journal Article
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias
Tursky, M L, Beck, D, Thoms, J A I, Huang, Y, Kumari, A, Unnikrishnan, A, Knezevic, K, Evans, K, Richards, L A, Lee, E, Morris, J, Goldberg, L, Izraeli, S, Wong, J W H, Olivier, J, Lock, R B, MacKenzie, K L, Pimanda, J E
Published in Leukemia (01.04.2015)
Published in Leukemia (01.04.2015)
Get full text
Journal Article
MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation
Huang, Y, Thoms, J A I, Tursky, M L, Knezevic, K, Beck, D, Chandrakanthan, V, Suryani, S, Olivier, J, Boulton, A, Glaros, E N, Thomas, S R, Lock, R B, MacKenzie, K L, Bushweller, J H, Wong, J W H, Pimanda, J E
Published in Leukemia (01.07.2016)
Published in Leukemia (01.07.2016)
Get full text
Journal Article
Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response
Thoms, J W, Dal Pra, A, Anborgh, P H, Christensen, E, Fleshner, N, Menard, C, Chadwick, K, Milosevic, M, Catton, C, Pintilie, M, Chambers, A F, Bristow, R G
Published in British journal of cancer (21.08.2012)
Published in British journal of cancer (21.08.2012)
Get full text
Journal Article
IDH mutation status in prostate cancer
Ghiam, A F, Cairns, R A, Thoms, J, Dal Pra, A, Ahmed, O, Meng, A, Mak, T W, Bristow, R G
Published in Oncogene (16.08.2012)
Published in Oncogene (16.08.2012)
Get full text
Journal Article
Retrospective Review of Outcomes With Active Surveillance and Active Treatment for Early-Stage Prostate Cancer in a Contemporary Series
Nicholson, C, Sathya, J, Kamran, A, Thoms, J, Gadag, V
Published in International journal of radiation oncology, biology, physics (01.11.2015)
Published in International journal of radiation oncology, biology, physics (01.11.2015)
Get full text
Journal Article
A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients
Oram, S H, Thoms, J A I, Pridans, C, Janes, M E, Kinston, S J, Anand, S, Landry, J -R, Lock, R B, Jayaraman, P -S, Huntly, B J, Pimanda, J E, Göttgens, B
Published in Oncogene (28.10.2010)
Published in Oncogene (28.10.2010)
Get full text
Journal Article
P748: SINGLE CELL GENOTYPING OF MATCHED BONE MARROW AND PERIPHERAL BLOOD CELLS IN TREATMENT NAIVE AND AZA‐TREATED MDS AND CMML
Schnegg‐Kaufmann, A., Thoms, J., Bhuyan, G. S., Henry, H., Vaughan, L., Rutherford, K., Kakadia, P., Johansson, E., Failes, T., Greg, A., Koval, J., Lindeman, R., Warburton, P., Rodriguez‐Meira, A., Mead, A., Unnikrishnan, A., Bohlander, S., Pappaemmanuil, E., Faridani, O., Jolly, C., Zanini, F., Pimanda, J.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia
Oram, S H, Thoms, J, Sive, J I, Calero-Nieto, F J, Kinston, S J, Schütte, J, Knezevic, K, Lock, R B, Pimanda, J E, Göttgens, B
Published in Leukemia (01.06.2013)
Published in Leukemia (01.06.2013)
Get full text
Journal Article
Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy
Boström, P.J., Thoms, J., Sykes, J., Ahmed, O., Evans, A., van Rhijn, B.W. G., Mirtti, T., Stakhovskyi, O., Laato, M., Margel, D., Pintilie, M., Kuk, C., Milosevic, M., Zlotta, A.R., Bristow, R.G.
Published in Bladder cancer (07.01.2016)
Published in Bladder cancer (07.01.2016)
Get full text
Journal Article
MC13-0009 A prognostic CNA signature sub-stratifies intermediate-risk prostate cancer
Boutros, P.C, Lalonde, E, Ishkanian, A.S, Sykes, J, Moon, N, Zafarana, G, Thoms, J, Have, L.C, Malloff, C, Ramnarine, V.R, Meng, A, Mak, D.F.Y, Squire, J, Jurisica, I, Pintilie, M, Dal Pra, A, Lam, W.L, Milosevic, M, Bristow, R.G
Published in European journal of cancer (1990) (01.11.2013)
Published in European journal of cancer (1990) (01.11.2013)
Get full text
Journal Article